Kessler Topaz is investigating potential claims on behalf of current Veradigm Inc. (“Veradigm”) (Nasdaq: MDRX) stockholders (f/k/a Allscripts Healthcare Solutions) related to its recent announcement that the company will restate its financial information over a multi-year period.
Our investigation is focused on whether certain Veradigm directors and/or officers may have breached their fiduciary duties to stockholders by failing to implement internal control mechanisms and/or failing to properly monitor internal control mechanisms that harmed the company.
If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com, or fill out the form below.